BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16780932)

  • 1. Aspirin failure course during exercise and its connection with soluble CD40L.
    Kuliczkowski W; Kobusiak-Prokopowicz M; Prajs I; Karolko B; Mazurek W
    Thromb Res; 2007; 119(6):679-86. PubMed ID: 16780932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin resistance in ischaemic heart disease.
    Kuliczkowski W; Halawa B; Korolko B; Mazurek W
    Kardiol Pol; 2005 Jan; 62(1):14-25. PubMed ID: 15815775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.
    Restituto P; Colina I; Varo JJ; Varo N
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1072-7. PubMed ID: 20197504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of biochemical aspirin resistance at rest and immediately after exercise testing.
    Gulmez O; Yildirir A; Bal U; Konas ND; Aydinalp A; Demir O; Atar I; Ertan C; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):9-13. PubMed ID: 17179820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention.
    Obradovic SD; Antovic JP; Antonijevic NM; Ratkovic NG; Vojvodic DV; Subota VS; Gligic BLj; Obradovic DV; Marinkovic JM; Wallen HN
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):283-9. PubMed ID: 19318922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
    Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease.
    Pamukcu B; Oflaz H; Onur I; Midilli K; Yilmaz G; Yilmaz E; Nisanci Y
    Circ J; 2008 Jan; 72(1):61-6. PubMed ID: 18159101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.
    Mannini L; Marcucci R; Paniccia R; Antonucci E; Giglioli C; Valente S; Gori AM; Prisco D; Gensini GF; Abbate R
    Clin Hemorheol Microcirc; 2006; 35(1-2):175-81. PubMed ID: 16899924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
    Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
    Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels increase after exercise testing in patients with increased platelet reactivity.
    Gulmez O; Ertan C; Yildirir A; Konas D; Bal U; Aydinalp A; Demir O; Ozin B; Muderrisoglu H
    Coron Artery Dis; 2007 Sep; 18(6):437-42. PubMed ID: 17700214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.